What's new

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised

Mar 20, 2025 - 09:44
 0
Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

The New York Fashion Tech Lab Unveils The 2025 Cohort

Next Article

Niche Marketing Programs during ITB Asia 2025

Related Posts

Checklist for the submission of Type IA and Type IB (wi...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025

Meeting highlights from the Committee for Veterinary Me...

Mar 14, 2025  0